Market Trends of End-stage Renal Disease Industry
This section covers the major market trends shaping the End-stage Renal Disease Market according to our research experts:
Dialysis Segment by Treatment is Expected to Witness a Significant Growth over the Forecast Period
Dialysis is a procedure that removes waste products from the blood, such as urea and creatinine, as a result of impaired kidney function. It is frequently required for persons with chronic renal failure. The blood is cleansed, and extra fluid and toxins are eliminated during this operation.
Moreover, the demand for dialysis is expected to increase as the incidence of end-stage renal disease increases worldwide. The prevalence of end-stage renal disease (ESRD) is high and growing at a significant rate. According to the article published by the National Institute of Health (NIH) in 2021, nearly 786,000 people in the United States were living with ESRD, with 71% on dialysis and 29% with a kidney transplant. Meanwhile, the number of patients who initiated peritoneal dialysis and received a preemptive transplant reached an all-time high of 18,631. According to the American Society of Nephrology, funding for dialysis is rising in the United States.
The end-stage renal disease market is growing as the population increases globally, thus, raising funding for better dialysis products and services. For instance, on July 1, 2021, the Centers for Medicare & Medicaid Services (CMS) issued a proposed rule for the Prospective Payment System (PPS) for renal dialysis services. Under the ESRD PPS for 2022, Medicare is expected to pay USD 8.9 billion to approximately 7,700 ESRD facilities for furnishing renal dialysis services.
On the other hand, factors like the high prevalence of diabetics, hypertension, rising incidences of kidney failures, lack of kidney donors for transplantation, tedious kidney transplant procedure, and increasing demand for home peritoneal dialysis treatment drive the segmental growth over the forecast period.
Asia-Pacific is is Expected to Witness a High Growth over the Forecast Period
Asia-Pacific is expected to witness high growth in end-stage renal disease due to the presence of high disposable income and the high acceptance rate of technologically improved products. Moreover, high blood pressure and diabetes cases in the region may contribute to the market growth. According to the data from the International Diabetes Federation in December 2021, an estimated 90 million adults were living with diabetes in the South-East Asia (SEA) region in 2021. This is estimated to increase to 113 million by 2030 and 152 million by 2045. Moreover, according to the same source, 46 million adults living with diabetes in the IDF SEA Region are undiagnosed, accounting for 51% of the total number of adults living with diabetes in the region.
Additionally, growing patient affordability, an aging population, lifestyle stress, a broad population base, and improving diagnosis quality are expected to fuel market growth. According to a report published by the national health portal of the Indian Government in July 2022, it is estimated that every year about 2.2 lakh new patients of end-stage renal disease (ESRD) are increasing, resulting in demand for 3.4 crore dialysis every year. Approximately 4,950 dialysis centers were available, largely in the private sector in India. The presence of a large number of dialysis centers in this region and a rise in the number of patients with chronic renal and kidney diseases are expected to boost the market growth.
